GlassScriptPhysician profile
Audra M Birzer
NPI 1316572076
$3,313.06
in general payments reported to CMS, 2019-2025
50 companies · $1,378 in 2025
The $1,378 reported for 2025 was more than what 90% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $184 · 2022: $362 · 2023: $506 · 2024: $884 · 2025: $1,378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,747 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,747.04 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $292.83 | 2023-2025 | |
| Janssen Biotech, INC. | $278.08 | 2022-2025 | Darzalex, Tecvayli, Talvey |
| Astrazeneca Pharmaceuticals LP | $249.90 | 2022-2025 | Enhertu, Imfinzi |
| Stemline Therapeutics INC. | $211.57 | 2024-2025 | Orserdu, Elzonris |
| Tersera Therapeutics LLC | $189.88 | 2021-2025 | Zoladex, Xermelo, Quzyttir |
| Novocure INC. | $144.01 | 2025 | Optune Lua (Novottf-200t) |
| Sumitomo Pharma America, INC. | $119.37 | 2023-2025 | Orgovyx |
| Merck Sharp & Dohme LLC | $115.61 | 2022-2025 | Keytruda, Welireg, Lynparza |
| Blueprint Medicines Corporation | $105.65 | 2022-2025 | Ayvakit |
| Bayer Healthcare Pharmaceuticals INC. | $99.39 | 2021-2025 | |
| Incyte Corporation | $87.32 | 2021-2025 | Monjuvi, Zynyz, Jakafi |
| Coherus Oncology, INC. | $74.24 | 2021-2024 | |
| Genentech USA, INC. | $70.45 | 2024-2025 | Tecentriq, Polivy, Itovebi |
| Dendreon Pharmaceuticals LLC | $65.79 | 2023-2024 | Provenge |
| Servier Pharmaceuticals LLC | $64.92 | 2022-2025 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Audra Birzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.